Hydromorphone Hydrochloride Tablet, Extended Release
Product Images NDC 0574-0294

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 0574-0294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0g978rcf3

Label for hydromorphone hydrochloride extended-release tablets, 12 mg strength, oral dosage form. It indicates once daily dosing, restricts use to opioid tolerant patients, and includes 100 tablets. The label shows the NDC number 0574-0294-01 and is manufactured by Perrigo in Minneapolis, MN. Storage instructions and warnings about tablet integrity are also present.*

FDA Label Image

1b578rcf3

Hydromorphone hydrochloride 8 mg extended-release tablets label for oral use. The label indicates a quantity of 100 tablets, intended for opioid-tolerant patients. It includes instructions to swallow tablets whole and store at controlled room temperature. The labeler is Padagis US LLC with manufacturing by Perrigo in Minneapolis, MN.*

FDA Label Image

5p178rcf2

Label for hydromorphone hydrochloride extended-release tablets, 32 mg, oral dosage form by Padagis US LLC. The label states the product is for opioid-tolerant patients only, with 100 tablets per container. It instructs swallowing tablets whole and provides storage instructions. Manufactured by Perrigo in Minneapolis, MN.*

FDA Label Image

6p278rcf3

Label for hydromorphone hydrochloride extended-release tablets, 16 mg strength, oral dosage form. The label indicates a 100-tablet bottle and includes instructions to swallow tablets whole without breaking or chewing. It specifies use for opioid tolerant patients only and includes manufacturer information, Perrigo. Storage instructions and a barcode are also visible.*

FDA Label Image

Figure-2.jpg (Figure 2)

A line graph comparing the percentage of patients improved at week 12 between hydromorphone hydrochloride extended-release tablets and placebo. The x-axis represents percent of reduction or improvement in pain (0 to 100%), and the y-axis shows the percentage of patients improved. Two lines plot results for hydromorphone hydrochloride and placebo groups.*

FDA Label Image

Figure One

A line graph titled 'Mean Steady-State Plasma Concentration Profile' showing plasma hydromorphone concentration (ng/mL) over time (hours). It compares Hydromorphone Hydrochloride Extended-Release Tablets 16 mg given every 24 hours with HMIR 4 mg given every 6 hours, displaying their concentration levels between 96 and 120 hours.*

FDA Label Image

Chemical-structure (Image 01)

Chemical structure of hydromorphone hydrochloride showing its molecular arrangement including a benzene ring, hydroxyl group, and hydrochloride component.*

FDA Label Image

Serialization Template 01

A drug facts panel placeholder including fields for serial number (S/N), lot number, and expiration date (Exp) to be filled in with specific product information. The text is in a black rectangular border on a white background.*

FDA Label Image

Serialization Template 02

A drug information panel template showing placeholders for serial number (S/N), lot number, and expiration date (Exp) with instructions to insert the product's specific details. The format is presented in a simple, black-bordered box with clear labels.*

FDA Label Image

Serialization Template 03

Label panel showing placeholders for serial number (S/N), lot number, and expiration date (Exp) for a pharmaceutical product, formatted as text fields to be filled with specific product information.*

FDA Label Image

Serialization Template

A black-and-white label panel showing placeholders for product information including serial number (S/N), lot number (Lot), and expiration date (Exp). Text prompts users to insert the product's serial number, lot number, and expiration date accordingly. No specific drug branding or strength is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.